Aryl hydroxamic acid analogues as potential therapeutic agents /
| dc.contributor.author | Tays, Kevin. | en_US |
| dc.contributor.department | Department of Chemistry | en_US |
| dc.date.accessioned | 2009-05-21T12:53:04Z | |
| dc.date.available | 2009-05-21T12:53:04Z | |
| dc.date.issued | 1997-05-21T12:53:04Z | |
| dc.description.abstract | A new synthetic pathway to analogues of the aglucones of naturally occurring cyclic hydroxamic acids (2,4-dihydroxy-l,4-benzoxazin-3-ones) has been developed. The new pathway involves the coupling of substituted nitrophenols wdth /-propyl-abromo- O-methoxymethylglycolate. These materials were reductively cyclised to reveal the hydroxamic acid functionality. Removal of the C-2 0-methoxymethyl protecting group was achieved chemoselectively using boron trichloride. The analogue 7-methoxy-2,4-dihydroxy-l,4-benzoxazin-3-one (DIMBOA) was assayed with papain and a semilog plot of activity of papain in the presence of excess DIMBOA was found to be linear. A single exponential equation was suggested as the model for kinetic analysis. '^ Nuclear magnetic resonance (NMR) spectra of a couple of hydroxamates were acquired as reference standards for future mechanistic studies of these compounds as thiol protease inhibitors. A 10% '^-labeled sample ofDIMBOA was also prepared for future mechanistic studies using NMR techniques. | en_US |
| dc.identifier.uri | http://hdl.handle.net/10464/1221 | |
| dc.language.iso | eng | en_US |
| dc.subject | Hydroxamic acids. | en_US |
| dc.subject | Protease inhibitors. | en_US |
| dc.title | Aryl hydroxamic acid analogues as potential therapeutic agents / | en_US |
| dc.type | Electronic Thesis or Dissertation | en |
| refterms.dateFOA | 2021-08-07T02:14:02Z | |
| thesis.degree.discipline | Faculty of Mathematics and Science | |
| thesis.degree.grantor | Brock University | |
| thesis.degree.level | Masters | |
| thesis.degree.name | M.Sc. Chemistry |
Files
Original bundle
1 - 1 of 1